Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Shares Outstanding (Weighted Average): 2016-2025

Historic Shares Outstanding (Weighted Average) for Tg Therapeutics (TGTX) over the last 10 years, with Sep 2025 value amounting to $158.7 million.

  • Tg Therapeutics' Shares Outstanding (Weighted Average) rose 1.93% to $158.7 million in Q3 2025 from the same period last year, while for Mar 2024 it was $154.4 million, marking a year-over-year increase of 5.51%. This contributed to the annual value of $155.7 million for FY2024, which is 2.81% up from last year.
  • Latest data reveals that Tg Therapeutics reported Shares Outstanding (Weighted Average) of $158.7 million as of Q3 2025, which was down 0.06% from $158.8 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Shares Outstanding (Weighted Average) registered a high of $158.8 million during Q2 2025, and its lowest value of $140.6 million during Q1 2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $153.9 million, with a median of $154.5 million in 2024.
  • Data for Tg Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 28.51% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Shares Outstanding (Weighted Average) stood at $142.9 million in 2021, then climbed by 1.68% to $145.3 million in 2022, then climbed by 4.18% to $151.4 million in 2023, then increased by 2.81% to $155.7 million in 2024, then increased by 1.93% to $158.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $158.7 million for Q3 2025, versus $158.8 million for Q2 2025 and $157.1 million for Q1 2025.